Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases

被引:12
作者
Baverez, Clara [1 ]
Grall, Maximilien [2 ]
Gerfaud-Valentin, Mathieu [1 ]
De Gail, Sarah [3 ]
Belot, Alexandre [4 ,5 ]
Perpoint, Thomas [6 ]
Weber, Emmanuelle [1 ]
Reynaud, Quitterie [7 ,8 ]
Seve, Pascal [1 ,8 ]
Jamilloux, Yvan [1 ,5 ]
机构
[1] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Serv Med Interne, Hop Croix Rousse, F-69008 Lyon, France
[2] Univ Rouen, Hop Hospitalo Univ Rouen, Serv Med Intens & Reanimat, F-76000 Rouen, France
[3] Univ Rouen, Hop Hospitalo Univ Rouen, Serv Med Interne, F-76000 Rouen, France
[4] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Serv Rhumato Nephro Dermatol Pediat, Hop Femme Mere Enfants, F-69008 Lyon, France
[5] Univ Claude Bernard Lyon 1, Lyon Immunopathol FEderat LIFE, F-69100 Lyon, France
[6] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Serv Malad Infect & Trop, Hop Croix Rousse, F-69008 Lyon, France
[7] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Med Interne, F-69008 Lyon, France
[8] Univ Claude Bernard Lyon 1, INSERM U1290, Res Healthcare Performance RESHAPE, F-69100 Lyon, France
关键词
anakinra; interleukin-1; hemophagocytic lymphohistiocytosis; adult onset Still's disease; immunotherapy; cytokines; inflammatory mediators; MACROPHAGE ACTIVATION SYNDROME; DIAGNOSIS; ADULTS;
D O I
10.3390/jcm11195799
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening cytokine storm syndrome. There are no definitive guidelines for the management of secondary HLH (sHLH). A recent report by a National Health Service (NHS) clinical panel has recommended anakinra as a treatment option. We aimed to analyse the efficacy and safety of anakinra for the treatment of all-cause sHLH. We conducted a multicentric retrospective study in two French University hospitals and included all patients who had a diagnosis of sHLH and who received anakinra. Among 21 patients (median age, 45 years), 13 were men. Anakinra was used as first-line therapy in 10 patients, and as monotherapy in 5 patients. We found that anakinra was effective in 19/21 patients (90.5%), with fever resolution in 19 patients (90.5%) within a median of 1.0 day (1, 2). At the Day 7 assessment, the mean CRP concentration decreased significantly (p < 0.001), as did the mean ferritin (p = 0.011). Anakinra was generally safe and well tolerated and was discontinued for side effects in only three patients (14.3%). Anakinra is an efficient and safe treatment to control sHLH of various causes. These data, together with the recent report of the NHS panel, call for the rapid conduct of prospective randomized clinical trials.
引用
收藏
页数:9
相关论文
共 14 条
  • [1] Haemophagocytic lymphohistiocytosis in adult critical care
    Bauchmuller, Kris
    Manson, Jessica J.
    Tattersall, Rachel
    Brown, Michael
    McNamara, Christopher
    Singer, Mervyn
    Brett, Stephen J.
    [J]. JOURNAL OF THE INTENSIVE CARE SOCIETY, 2020, 21 (03) : 256 - 268
  • [2] Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment
    Carter, Stuart J.
    Tattersall, Rachel S.
    Ramanan, Athimalaipet V.
    [J]. RHEUMATOLOGY, 2019, 58 (01) : 5 - 17
  • [3] Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
    Eloseily, Esraa M.
    Weiser, Peter
    Crayne, Courtney B.
    Haines, Hilary
    Mannion, Melissa L.
    Stoll, Matthew L.
    Beukelman, Timothy
    Atkinson, T. Prescott
    Cron, Randy Q.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (02) : 326 - 334
  • [4] Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome
    Fardet, Laurence
    Galicier, Lionel
    Lambotte, Olivier
    Marzac, Christophe
    Aumont, Cedric
    Chahwan, Doumit
    Coppo, Paul
    Hejblum, Gilles
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) : 2613 - 2620
  • [5] Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU
    Gregory, Jillian
    Greenberg, Jay
    Basu, Sonali
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2019, 20 (04) : E185 - E190
  • [6] Macrophage activation syndrome in the era of biologic therapy
    Grom, Alexei A.
    Horne, AnnaCarin
    De Benedetti, Fabrizio
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (05) : 259 - 268
  • [7] Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review
    Hayden, Anna
    Park, Sujin
    Giustini, Dean
    Lee, Agnes Y. Y.
    Chen, Luke Y. C.
    [J]. BLOOD REVIEWS, 2016, 30 (06) : 411 - 420
  • [8] HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
    Henter, Jan-Inge
    Horne, AnnaCarin
    Arico, Maurizio
    Egeler, R. Maarten
    Filipovich, Alexandra H.
    Imashuku, Shinsaku
    Ladisch, Stephan
    McClain, Ken
    Webb, David
    Winiarski, Jacek
    Janka, Gritta
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (02) : 124 - 131
  • [9] A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults
    Kumar, Bharat
    Aleem, Sohaib
    Saleh, Hana
    Petts, Jennifer
    Ballas, Zuhair K.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (07) : 638 - 643
  • [10] An open label trial of anakinra to prevent respiratory failure in COVID-19
    Kyriazopoulou, Evdoxia
    Panagopoulos, Periklis
    Metallidis, Symeon
    Dalekos, George N.
    Poulakou, Garyphallia
    Gatselis, Nikolaos
    Karakike, Eleni
    Saridaki, Maria
    Loli, Georgia
    Stefos, Aggelos
    Prasianaki, Danai
    Georgiadou, Sarah
    Tsachouridou, Olga
    Petrakis, Vasileios
    Tsiakos, Konstantinos
    Kosmidou, Maria
    Lygoura, Vassiliki
    Dareioti, Maria
    Milionis, Haralampos
    Papanikolaou, Ilias C.
    Akinosoglou, Karolina
    Myrodia, Dimitra-Melia
    Gravvani, Areti
    Stamou, Aliki
    Gkavogianni, Theologia
    Katrini, Konstantina
    Marantos, Theodoros
    Trontzas, Ioannis P.
    Syrigos, Konstantinos
    Chatzis, Loukas
    Chatzis, Stamatios
    Vechlidis, Nikolaos
    Avgoustou, Christina
    Chalvatzis, Stamatios
    Kyprianou, Miltiades
    van der Meer, Jos Wm
    Eugen-Olsen, Jesper
    Netea, Mihai G.
    Giamarellos-Bourboulis, Evangelos J.
    [J]. ELIFE, 2021, 10